Literature DB >> 7929814

The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo.

W L Hutchinson1, G E Noble, P N Hawkins, M B Pepys.   

Abstract

The cellular sites of clearance and degradation of the pentraxin plasma proteins, C-reactive protein, the classical acute phase reactant, and serum amyloid P component (SAP), a universal constituent of amyloid deposits, were sought using the ligand 125I-tyramine cellobiose (TC) which is substantially retained within the cells in which catabolism takes place. Pentraxins labeled with 125I-TC showed the same in vitro and in vivo ligand binding and the same in vivo plasma t1/2 as the directly iodinated proteins and the native unlabeled pentraxins, indicating that their mode of clearance was likely to be physiological. After intravenous injection into mice and rabbits of human C-reactive protein, human SAP, and mouse SAP, each labeled with 125I-TC, most of the radioactivity remaining in the body at 24 h was located in hepatocytes. None was detected in other liver cells, and only traces were present in other viscera; the rest was in the carcass, representing intact pentraxins in the blood and extravascular compartment, and escaped label which had not yet been excreted. Hepatocytes are thus the single major site of pentraxin clearance and catabolism in vivo. This is consistent with the observation that SAP that has localized to amyloid deposits persists there and is not degraded.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929814      PMCID: PMC295264          DOI: 10.1172/JCI117474

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  EXPERIMENTAL AMYLOIDOSIS: STUDIES WITH A MODIFIED CASEIN METHOD, CASEIN HYDROLYSATE AND GELATIN.

Authors:  D T JANIGAN
Journal:  Am J Pathol       Date:  1965-07       Impact factor: 4.307

2.  Serum amyloid P-component is an acute-phase reactant in the mouse.

Authors:  M B Pepys; M Baltz; K Gomer; A J Davies; M Doenhoff
Journal:  Nature       Date:  1979-03-15       Impact factor: 49.962

3.  Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure.

Authors:  M B Pepys; T W Rademacher; S Amatayakul-Chantler; P Williams; G E Noble; W L Hutchinson; P N Hawkins; S R Nelson; J R Gallimore; J Herbert
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

4.  Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression.

Authors:  P N Hawkins; S Richardson; J E MacSweeney; A D King; D M Vigushin; J P Lavender; M B Pepys
Journal:  Q J Med       Date:  1993-06

5.  Specific chemical dissociation of fibrillar and non-fibrillar components of amyloid deposits.

Authors:  C R Hind; P M Collins; D Caspi; M L Baltz; M B Pepys
Journal:  Lancet       Date:  1984-08-18       Impact factor: 79.321

6.  Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease.

Authors:  D M Vigushin; M B Pepys; P N Hawkins
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

7.  Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum.

Authors:  M B Pepys; A C Dash; R E Markham; H C Thomas; B D Williams; A Petrie
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

8.  In vivo turnover studies of C-reactive protein and lipoproteins in the rabbit.

Authors:  I F Rowe; M L Baltz; A K Soutar; M B Pepys
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

9.  Structure of pentameric human serum amyloid P component.

Authors:  J Emsley; H E White; B P O'Hara; G Oliva; N Srinivasan; I J Tickle; T L Blundell; M B Pepys; S P Wood
Journal:  Nature       Date:  1994-01-27       Impact factor: 49.962

10.  Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis.

Authors:  P N Hawkins; S Richardson; D M Vigushin; J David; C R Kelsey; R E Gray; M A Hall; P Woo; J P Lavender; M B Pepys
Journal:  Arthritis Rheum       Date:  1993-06
View more
  20 in total

1.  Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component.

Authors:  Simon E Kolstoe; Basil H Ridha; Vittorio Bellotti; Nan Wang; Carol V Robinson; Sebastian J Crutch; Geoffrey Keir; Riitta Kukkastenvehmas; J Ruth Gallimore; Winston L Hutchinson; Philip N Hawkins; Stephen P Wood; Martin N Rossor; Mark B Pepys
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-16       Impact factor: 11.205

2.  Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s.

Authors:  Chris T Longenecker; Douglas Kitch; Paul E Sax; Eric S Daar; Camlin Tierney; Samir K Gupta; Grace A McComsey
Journal:  J Acquir Immune Defic Syndr       Date:  2015-06-01       Impact factor: 3.731

Review 3.  Imaging amyloidosis with radiolabelled SAP.

Authors:  P N Hawkins; M B Pepys
Journal:  Eur J Nucl Med       Date:  1995-07

4.  Combined Biomarkers Predict Acute Mortality Among Critically Ill Patients With Suspected Sepsis.

Authors:  Brendan J Kelly; Ebbing Lautenbach; Irving Nachamkin; Susan E Coffin; Jeffrey S Gerber; Barry D Fuchs; Charles Garrigan; Xiaoyan Han; Warren B Bilker; Jacqueleen Wise; Pam Tolomeo; Jennifer H Han
Journal:  Crit Care Med       Date:  2018-07       Impact factor: 7.598

5.  Dietary modulation and structure prediction of rat mucosal pentraxin (Mptx) protein and loss of function in humans.

Authors:  Cindy van der Meer-van Kraaij; Roland Siezen; Evelien Kramer; Marjolein Reinders; Hans Blokzijl; Roelof van der Meer; Jaap Keijer
Journal:  Genes Nutr       Date:  2007-10-16       Impact factor: 5.523

6.  Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis.

Authors:  G A Tennent; L B Lovat; M B Pepys
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

7.  Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination?

Authors:  Julian D Gillmore; Winston L Hutchinson; Jeff Herbert; Alison Bybee; Daniel A Mitchell; Robert P Hasserjian; Ken-Ichi Yamamura; Misao Suzuki; Caroline A Sabin; Mark B Pepys
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

Review 8.  Pentraxins and Fc receptors.

Authors:  Jinghua Lu; Kristopher D Marjon; Carolyn Mold; Terry W Du Clos; Peter D Sun
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

Review 9.  C-reactive protein and the biology of disease.

Authors:  Waliza Ansar; Shyamasree Ghosh
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

10.  C-reactive protein and the acute phase reaction in geriatric patients.

Authors:  Thomas Bertsch; Jakob Triebel; Cornelius Bollheimer; Michael Christ; Cornel Sieber; Klaus Fassbender; Hans Jürgen Heppner
Journal:  Z Gerontol Geriatr       Date:  2015-09-03       Impact factor: 1.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.